A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immucell Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 149,489 shares of ICCC stock, worth $705,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,489
Previous 125,589 19.03%
Holding current value
$705,588
Previous $609,000 11.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.53 - $4.46 $84,367 - $106,594
23,900 Added 19.03%
149,489 $542,000
Q2 2024

Aug 09, 2024

BUY
$4.18 - $5.48 $2,926 - $3,836
700 Added 0.56%
125,589 $609,000
Q1 2024

May 13, 2024

SELL
$4.73 - $5.47 $6,149 - $7,111
-1,300 Reduced 1.03%
124,889 $662,000
Q4 2023

Feb 13, 2024

BUY
$4.45 - $5.47 $21,400 - $26,305
4,809 Added 3.96%
126,189 $642,000
Q3 2023

Nov 14, 2023

SELL
$4.53 - $5.61 $4,570 - $5,660
-1,009 Reduced 0.82%
121,380 $648,000
Q2 2023

Aug 11, 2023

SELL
$4.64 - $5.98 $2,032 - $2,619
-438 Reduced 0.36%
122,389 $612,000
Q1 2023

May 12, 2023

SELL
$4.85 - $7.84 $12,910 - $20,870
-2,662 Reduced 2.12%
122,827 $633,000
Q4 2022

Feb 13, 2023

SELL
$6.09 - $8.25 $73,670 - $99,800
-12,097 Reduced 8.79%
125,489 $765,000
Q3 2022

Nov 14, 2022

SELL
$7.04 - $9.1 $114,055 - $147,429
-16,201 Reduced 10.53%
137,586 $1.03 Million
Q2 2022

Aug 12, 2022

SELL
$7.7 - $10.71 $6,098 - $8,482
-792 Reduced 0.51%
153,787 $1.34 Million
Q1 2022

May 13, 2022

SELL
$8.0 - $10.06 $104,296 - $131,152
-13,037 Reduced 7.78%
154,579 $1.49 Million
Q4 2021

Feb 11, 2022

SELL
$8.0 - $9.74 $69,648 - $84,796
-8,706 Reduced 4.94%
167,616 $1.34 Million
Q3 2021

Nov 12, 2021

SELL
$8.54 - $10.24 $15,662 - $18,780
-1,834 Reduced 1.03%
176,322 $1.65 Million
Q2 2021

Aug 13, 2021

SELL
$8.5 - $10.95 $80,087 - $103,170
-9,422 Reduced 5.02%
178,156 $1.69 Million
Q1 2021

May 13, 2021

BUY
$5.98 - $11.88 $116,161 - $230,769
19,425 Added 11.55%
187,578 $1.81 Million
Q4 2020

Feb 10, 2021

BUY
$5.21 - $6.42 $62,681 - $77,239
12,031 Added 7.71%
168,153 $1 Million
Q3 2020

Nov 13, 2020

BUY
$4.98 - $6.35 $91,881 - $117,157
18,450 Added 13.4%
156,122 $848,000
Q2 2020

Aug 13, 2020

BUY
$3.95 - $4.9 $78,210 - $97,020
19,800 Added 16.8%
137,672 $651,000
Q1 2020

May 14, 2020

BUY
$3.79 - $5.92 $29,433 - $45,974
7,766 Added 7.05%
117,872 $447,000
Q4 2019

Feb 13, 2020

BUY
$4.81 - $5.57 $67,340 - $77,980
14,000 Added 14.57%
110,106 $567,000
Q3 2019

Nov 13, 2019

BUY
$5.15 - $6.55 $21,115 - $26,855
4,100 Added 4.46%
96,106 $535,000
Q2 2019

Aug 12, 2019

BUY
$5.89 - $6.86 $4,123 - $4,802
700 Added 0.77%
92,006 $598,000
Q1 2019

May 14, 2019

SELL
$5.91 - $8.09 $2,955 - $4,045
-500 Reduced 0.54%
91,306 $580,000
Q4 2018

Feb 13, 2019

BUY
$6.4 - $9.03 $587,558 - $829,008
91,806 New
91,806 $647,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $36.6M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.